Inventor
HEMMI KEIJI
JP50 patents
⚠️ This page may combine multiple inventors who share the name “HEMMI KEIJI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
FUJISAWA PHARMACEUTICAL CO
46 patentsUS4963530AOct 16, 1990
Renin inhibitor peptide compounds, a process for the preparation thereof and pharmaceutical composition comprising the same
FUJISAWA PHARMACEUTICAL CO167 citations99
US5521170AMay 28, 1996
Benzamide derivatives and pharmaceutical composition comprising the same
FUJISAWA PHARMACEUTICAL CO70 citations96
US4940709AJul 10, 1990
Piperazine compound as PAF-antagonist
FUJISAWA PHARMACEUTICAL CO67 citations96
US4806538AFeb 21, 1989
Piperazine compound as PAF-antagonist
FUJISAWA PHARMACEUTICAL CO52 citations96
US6211242B1Apr 3, 2001
Benzamide derivatives as vasopressin antagonists
FUJISAWA PHARMACEUTICAL CO35 citations92
US5430022AJul 4, 1995
Peptide compound and its preparation
FUJISAWA PHARMACEUTICAL CO29 citations92
US5284828AFeb 8, 1994
Peptide compound and its preparation
FUJISAWA PHARMACEUTICAL CO33 citations90
US5187195AFeb 16, 1993
Anthraquinone derivatives and preparation thereof
FUJISAWA PHARMACEUTICAL CO45 citations90
US4206156AJun 3, 1980
Hydroxyaminohydrocarbonphosphonic acids
FUJISAWA PHARMACEUTICAL CO25 citations82
US4666890AMay 19, 1987
Peptide, process for preparation thereof and use thereof
FUJISAWA PHARMACEUTICAL CO16 citations81
US4311640AJan 19, 1982
Peptide, process for preparation thereof and use thereof
FUJISAWA PHARMACEUTICAL CO21 citations81
US4207234AJun 10, 1980
4-Unsubstituted azetidinone derivatives and process for preparation thereof
FUJISAWA PHARMACEUTICAL CO29 citations81
US5491132AFeb 13, 1996
Amino acid derivatives, a process for the preparation thereof and pharmaceutical composition comprising the same
FUJISAWA PHARMACEUTICAL CO11 citations74
US5142048AAug 25, 1992
Intermediate for preparation of amino acid derivatives
FUJISAWA PHARMACEUTICAL CO8 citations74
US4921855AMay 1, 1990
New Histidyl amino acid derivatives, and pharmaceutical composition comprising the same
FUJISAWA PHARMACEUTICAL CO10 citations74
US4234724ANov 18, 1980
Cephalosporin analogues and processes for the preparation thereof
FUJISAWA PHARMACEUTICAL CO5 citations74
US4182758AJan 8, 1980
Hydroxyaminohydrocarbonphosphonic acid derivatives and use thereof as an antibiotic
FUJISAWA PHARMACEUTICAL CO9 citations74
US4172198AOct 23, 1979
7-(N-substituted-2-phenylglycinamido)-3-substituted-3-cephem-4-carboxylic acid compounds and preparation thereof
FUJISAWA PHARMACEUTICAL CO5 citations74
US4077965AMar 7, 1978
Aminoalkyl- or hydroxyalkyl-substituted thiadiazole derivatives
FUJISAWA PHARMACEUTICAL CO7 citations74
US6426345B1Jul 30, 2002
Heterobicyclic derivatives
FUJISAWA PHARMACEUTICAL CO10 citations73
US6110933AAug 29, 2000
Amino acid derivatives and their use as phospholipase A2 inhibitor
FUJISAWA PHARMACEUTICAL CO9 citations73
US5656604AAug 12, 1997
Peptide compound and its preparation
FUJISAWA PHARMACEUTICAL CO9 citations73
US5538950AJul 23, 1996
Endothelin antagonists and their preparation
FUJISAWA PHARMACEUTICAL CO8 citations73
US5296591AMar 22, 1994
Trifluoromethylketone derivatives, processes for preparation thereof and use thereof
FUJISAWA PHARMACEUTICAL CO11 citations73
US4801580AJan 31, 1989
Peptide, process for preparation thereof and use thereof
FUJISAWA PHARMACEUTICAL CO10 citations73
US4512980AApr 23, 1985
Peptide, process for preparation thereof and use thereof
FUJISAWA PHARMACEUTICAL CO2 citations63
US4497801AFeb 5, 1985
New peptides, process for preparation thereof and use thereof
FUJISAWA PHARMACEUTICAL CO5 citations63
US4354966AOct 19, 1982
Peptides, process for preparation thereof and use thereof
FUJISAWA PHARMACEUTICAL CO5 citations63
US4342760AAug 3, 1982
Cephalosporin analogues
FUJISAWA PHARMACEUTICAL CO3 citations63
US4205166AMay 27, 1980
7-Substituted-3-aminoalkyl-, acylaminoalkyl-, or hydroxyalkyl-substituted heterocyclic thiomethyl-3-cephem-4-carboxylic acid derivatives and preparation thereof
FUJISAWA PHARMACEUTICAL CO2 citations63
US6727245B2Apr 27, 2004
Heterobicyclic derivatives
FUJISAWA PHARMACEUTICAL CO5 citations62
US5888972AMar 30, 1999
Peptide compounds, their preparation and uses
FUJISAWA PHARMACEUTICAL CO4 citations62
US5430025AJul 4, 1995
Elastase-inhibiting peptides bearing a C-terminal trifluoromethylketone moiety
FUJISAWA PHARMACEUTICAL CO2 citations62
US4497729AFeb 5, 1985
Peptide, process for preparation thereof and use thereof
FUJISAWA PHARMACEUTICAL CO3 citations62
US4493794AJan 15, 1985
Peptide, process for preparation thereof and use thereof
FUJISAWA PHARMACEUTICAL CO3 citations62
US4458078AJul 3, 1984
Oxazole derivatives
FUJISAWA PHARMACEUTICAL CO4 citations62
US4725582AFeb 16, 1988
Peptide, process for preparation thereof and use thereof
FUJISAWA PHARMACEUTICAL CO1 citations61
US6207686B1Mar 27, 2001
Endothelin antagonists
FUJISAWA PHARMACEUTICAL CO1 citations52
US4487763ADec 11, 1984
Peptide, process for preparation thereof and use thereof
FUJISAWA PHARMACEUTICAL CO1 citations52
US4472300ASep 18, 1984
Azetidinone derivatives and process for preparation thereof
FUJISAWA PHARMACEUTICAL CO1 citations52
US4324892AApr 13, 1982
7-(N-Substituted-2-phenylglycinamido)-3-substituted-3-cephem-4-carboxylic acid compounds
FUJISAWA PHARMACEUTICAL CO1 citations52
US5057513AOct 15, 1991
Spiro-thiazepine derivatives useful as paf antagonists
FUJISAWA PHARMACEUTICAL CO1 citations51
US4749691AJun 7, 1988
Peptide, process for preparation thereof and use thereof
FUJISAWA PHARMACEUTICAL CO0 citations51
US4476050AOct 9, 1984
Peptide, process for preparation thereof and use thereof
FUJISAWA PHARMACEUTICAL CO1 citations51
US4460502AJul 17, 1984
Peptide, process for preparation thereof and use thereof
FUJISAWA PHARMACEUTICAL CO0 citations48
US4350694ASep 21, 1982
Cephalosporin analogues and antimicrobial compositions
FUJISAWA PHARMACEUTICAL CO0 citations44